Sol Gel Company Leadership
| SLGL Stock | USD 72.10 2.60 3.74% |
Sol Gel employs about 34 people. The company is managed by 9 executives with a total tenure of roughly 29 years, averaging almost 3.0 years of service per executive, having 3.78 employees per reported executive. Inspection of Sol Gel's management performance can provide insight into the company performance.
| Alon SeriLevy CEO CEO, Co-Founder, Director |
| Itzik Yosef President Vice President - Operations |
Sol Gel's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Sol Gel's future performance. Based on our forecasts, it is anticipated that Sol will maintain a workforce of about 50 employees by February 2026.Sol Gel Management Team Effectiveness
The company has return on total asset (ROA) of (0.0733) % which means that it has lost $0.0733 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1021) %, meaning that it created substantial loss on money invested by shareholders. Sol Gel's management efficiency ratios could be used to measure how well Sol Gel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.28. Return On Capital Employed is expected to rise to -0.43 this year. At this time, Sol Gel's Fixed Asset Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0.30 this year, although the value of Other Assets will most likely fall to 1.09.The value of Common Stock Shares Outstanding is expected to slide to about 20.6 M. The value of Net Loss is expected to slide to about (14.1 M)The market capitalization of Sol Gel is $99.1 Million. Sol Gel Technologies has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.0 % of Sol Gel outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Shares in Circulation | First Issued 2016-03-31 | Previous Quarter 2.8 M | Current Value 2.8 M | Avarage Shares Outstanding 19.4 M | Quarterly Volatility 7.4 M |
Sol Gel Workforce Comparison
Sol Gel Technologies is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 833. Sol Gel holds roughly 34.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.65 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.65. Sol Gel Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sol Gel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sol Gel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sol Gel insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sol Gel Notable Stakeholders
A Sol Gel stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sol Gel often face trade-offs trying to please all of them. Sol Gel's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sol Gel's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Alon SeriLevy | CEO, Co-Founder, Director | Profile | |
| Moshe Arkin | Interim Chairman | Profile | |
| Itzik Yosef | Vice President - Operations | Profile | |
| Karine Neimann | Vice President - Projects and Planning, Chief Chemist | Profile | |
| Tamar Jutkowitz | VP Counsel | Profile | |
| Gilad Mamlok | Chief Officer | Profile | |
| Michael Glezin | Chief Officer | Profile | |
| Pr Avnir | CoFounder | Profile | |
| Eyal BenOr | Chief Officer | Profile |
About Sol Gel Management Performance
The success or failure of an entity such as Sol Gel Technologies often depends on how effective the management is. Sol Gel management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | (0.45) | (0.43) | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | (0.42) | (0.40) |
Sol Gel Workforce Analysis
Traditionally, organizations such as Sol Gel use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sol Gel within its industry.Sol Gel Manpower Efficiency
Return on Sol Gel Manpower
| Revenue Per Employee | 339.4K | |
| Revenue Per Executive | 1.3M | |
| Net Loss Per Employee | 311.2K | |
| Net Loss Per Executive | 1.2M | |
| Working Capital Per Employee | 765K | |
| Working Capital Per Executive | 2.9M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.876 | Earnings Share (1.22) | Revenue Per Share | Quarterly Revenue Growth 2.177 | Return On Assets |
The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.